<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmedpharm</journal-id><journal-title-group><journal-title xml:lang="ru">Фармация и фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacy &amp; Pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2307-9266</issn><issn pub-type="epub">2413-2241</issn><publisher><publisher-name>Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical Univer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.19163/2307-9266-2024-12-1-4-14</article-id><article-id custom-type="elpub" pub-id-type="custom">pmedpharm-1445</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH ARTICLE</subject></subj-group></article-categories><title-group><article-title>Оценка эффективности серосодержащих аминокислот у крыс с экспериментальным «алкогольным похмельем» с помощью методики зоосоциального взаимодействия</article-title><trans-title-group xml:lang="en"><trans-title>Effectiveness assessment of sulfur-containing amino acids in rats with experimental “alcohol withdrawal syndrome” with modified zoosocial interaction methods</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0258-4092</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петров</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, академик РАН, заведующий кафедрой клинической фармакологии и интенсивной терапии, ФГБОУ ВО ВолгГМУ Минздрава России; главный внештатный специалист – клинический фармаколог Министерства здравоохранения РФ; заслуженный деятель науки РФ; заслуженный врач РФ. </p><p>400131, Россия, г. Волгоград, пл. Павших Борцов, д. 1</p></bio><bio xml:lang="en"><p>Doctor of Sciences (Medicine), Professor, Academician of the Russian Academy of Sciences, Head of the Department of Clinical Pharmacology and Intensive Care, Volgograd State Medical University of the Ministry of Health of Russia; chief freelance specialist – clinical pharmacologist of the Ministry of Health of the Russian Federation; Honored Scientist of the Russian Federation; Honored Doctor of the Russian Federation.</p><p>1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131</p></bio><email xlink:type="simple">brain@sprintnet.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7398-2186</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осадченко</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Osadchenko</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>очный аспирант кафедры клинической фармакологии и интенсивной терапии ФГБОУ ВО ВолгГМУ Минздрава России. </p><p>400131, Россия, г. Волгоград, пл. Павших Борцов, д. 1</p></bio><bio xml:lang="en"><p>full-time postgraduate student of the Department of Clinical Pharmacology and Intensive Care at Volgograd State Medical University.</p><p>1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131</p></bio><email xlink:type="simple">n.a.osadchenko@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8581-1595</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарасов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarasov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры фундаментальной медицины и биологии ФГБОУ ВО ВолгГМУ Минздрава России; младший научный сотрудник лаборатории нейропсихотропных средств НЦИЛС ФГБОУ ВО ВолгГМУ Минздрава России.</p><p>400131, Россия, г. Волгоград, пл. Павших Борцов, д. 1.</p><p>400087, Россия, г. Волгоград, ул. Новороссийская, д. 39</p></bio><bio xml:lang="en"><p>Junior Researcher at the Laboratory of Neuropsychotropic Drugs of the Scientific Center for Innovative Medicines of Volgograd State Medical University.</p><p>1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131.</p><p>39, Novorossiyskaya Str., Volgograd, Russia, 400087.</p></bio><email xlink:type="simple">tarasov.pharm@ya.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3324-3351</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Доценко</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Dotsenko</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры фундаментальной медицины и биологии, заочный аспирант кафедры клинической фармакологии и интенсивной терапии ФГБОУ ВО ВолгГМУ Минздрава России; младший научный сотрудник лаборатории фармакокинетики НЦИЛС ФГБОУ ВО ВолгГМУ Минздрава России.</p><p>400131, Россия, г. Волгоград, пл. Павших Борцов, д. 1.</p><p>400087, Россия, г. Волгоград, ул. Новороссийская, д. 39</p></bio><bio xml:lang="en"><p>Assistant at the Department of Fundamental Medicine and Biology, part-time postgraduate student of the Department of Clinical Pharmacology and Intensive Care at Volgograd State Medical University, Junior Researcher at the Laboratory of Genomic and Proteomic Research of the Scientific Center for Innovative Medicines of Volgograd State Medical University</p><p>1, Pavshikh Bortsov Sq., Volgograd, Russia, 400131.</p></bio><email xlink:type="simple">ev8278@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7119-3546</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Морковин</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Morkovin</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент, заведующий лабораторией нейропсихофармакологии НЦИЛС ФГБОУ ВО ВолгГМУ Минздрава России.</p><p>400087, Россия, г. Волгоград, ул. Новороссийская, д. 39</p></bio><bio xml:lang="en"><p>Candidate of Sciences (Medicine), Associate Professor, Head of the Laboratory of Neuropsychotropic Drugs at the Scientific Center for Innovative Medicines of Volgograd State Medical University.</p><p>39, Novorossiyskaya Str., Volgograd, Russia, 400087</p></bio><email xlink:type="simple">e.i.morkovin@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Volgograd State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>1. Федеральное государственное бюджетное образовательное учреждение высшего образования «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации.&#13;
2. Научный центр инновационных лекарственных средств с опытно-промышленным производством федерального государственного бюджетного образовательного учреждения высшего образования «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации.</institution><country>Россия</country></aff><aff xml:lang="en"><institution>1. Volgograd State Medical University.&#13;
2. Scientific Center of Innovative Medicines.</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>1. Федеральное государственное бюджетное образовательное учреждение высшего образования «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации.&#13;
2. Научный центр инновационных лекарственных средств с опытно-промышленным производством федерального государственного бюджетного образовательного учреждения высшего образования «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации.</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Volgograd State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Научный центр инновационных лекарственных средств с опытно-промышленным производством федерального государственного бюджетного образовательного учреждения высшего образования «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Center of Innovative Medicines</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>07</day><month>05</month><year>2024</year></pub-date><volume>12</volume><issue>1</issue><fpage>4</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Петров В.И., Осадченко Н.А., Тарасов А.С., Доценко А.М., Морковин Е.И., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Петров В.И., Осадченко Н.А., Тарасов А.С., Доценко А.М., Морковин Е.И.</copyright-holder><copyright-holder xml:lang="en">Petrov V.I., Osadchenko N.A., Tarasov A.S., Dotsenko A.M., Morkovin E.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmpharm.ru/jour/article/view/1445">https://www.pharmpharm.ru/jour/article/view/1445</self-uri><abstract><sec><title>Цель</title><p>Цель. Сравнить влияние адеметионина, ацетилцистеина и таурина на зоосоциальное поведение крыс, находящихся в постинтоксикационном состоянии после острого отравления этанолом.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Исследование проведено на крысах-самцах линии Wistar. Постинтоксикационное состояние моделировали однократным введением этанола (3 г/кг, внутрибрюшинно). Через 30 мин после пробуждения животным вводили: физиологический раствор, ацетилцистеин (1 г/кг), адеметионин (100 мг/кг) или таурин (40 мг/кг). Через 30 мин после введения проводили тест зоосоциального взаимодействия.</p></sec><sec><title>Результаты</title><p>Результаты. Среди исследуемых показателей поведения были приняты во внимание: количество актов замирания, длительность следования, количество актов обнюхивания спереди, количество актов избегания и количество вертикальных стоек без опоры (p &lt;0,05 между показателями групп отрицательного и положительного контроля во всех случаях). Введение ацетилцистеина, адеметионина и таурина снижало количество актов замирания на 53,64, 7,27 и 24,51% соответственно (p &lt;0,05 при сравнении с показателем у животных из группы положительного контроля во всех случаях). Введение ацетилцистеина и таурина снижало количество актов избегания на 50 и 10% соответственно (p &lt;0,05 при сравнении с показателем у животных из группы положительного контроля в обоих случаях). Все аминокислоты нормализовали показатели коммуникативности, несмотря на то, что они не отличались от показателей у животных из группы положительного контроля (p &gt;0,05). Алкоголизация снижала количество вертикальных стоек на 65% (p &lt;0,001 при сравнении с показателем у животных из группы отрицательного контроля), а при последующем введении адеметионина и таурина снижение составило 38 и 36% соответственно (p &lt;0,05 при сравнении с показателем у животных из группы отрицательного контроля).</p></sec><sec><title>Заключение</title><p>Заключение. Согласно полученным данным, серосодержащие аминокислоты, в первую очередь те, что обладали центральными эффектами, нормализовали функции нейронов, положительно влияя на сложное поведение крыс. Учитывая результаты предыдущих исследований, удалось заключить, что терапевтическое действие адеметионина и таурина в контексте постинтоксикационного состояния опосредовано их центральными эффектами, не столь выраженными в сравнении с ацетилцистеином.</p></sec></abstract><trans-abstract xml:lang="en"><p>The aim of the work was to compare the effects of ademethionine, acetylcysteine and taurine on the zoosocial behavior of rats in a post-intoxicated state after an acute ethanol poisoning.</p><sec><title>Materials and methods</title><p>Materials and methods. The study was conducted on male rats of the Wistar line. The post-intoxication state was modeled by a single injection of ethanol (3 g/kg, intraperitoneally). 30 min after awakening, the animals were injected with a physiological solution, acetylcysteine (1 g/kg), ademetionine (100 mg/kg) or taurine (40 mg/kg). A zoosocial interaction test was performed 30 min after the administration.</p></sec><sec><title>Results</title><p>Results. Among the behavioral indicators investigated, the following were validated: the number of acts of freezing, their duration, the number of acts of sniffing in front, the number of acts of avoidance and the number of vertical stances without support (p &lt;0.05 between the values of the negative and positive control groups in all cases). The administration of acetylcysteine, ademetionine and taurine reduced the number of freezing acts by 53.64, 7.27 and 24.51%, respectively (p &lt;0.05 when compared with the indicator index in the animals from the positive control group in all cases). The administration of acetylcysteine and taurine reduced the number of avoidance acts by 50 and 10%, respectively (p &lt;0.05 when compared to that of the animals from the positive control group in both cases). All amino acids normalized the communicative performance, although it did not differ from that of the animals from the positive control group (p &gt;0.05). Alcoholization reduced the number of vertical stances by 65% (p &lt;0.001 when compared with that in the animals from the negative control group), and when followed by the administration of ademetionine and taurine, the reduction was 38 and 36%, respectively (p &lt;0.05 when compared to that in the animals from the negative control group).</p></sec><sec><title>Conclusion</title><p>Conclusion. According to the data obtained, sulfur-containing amino acids, primarily those that had central effects, normalized neuronal functions, positively influencing a complex behavior of rats. Taking into account the results of the previous studies, it was possible to conclude that the therapeutic effect of ademetionine and taurine in the context of a post-intoxication state is mediated by their central effects, which are not so pronounced in comparison with acetylcysteine.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>этанол</kwd><kwd>ацетилцистеин</kwd><kwd>таурин</kwd><kwd>адеметионин</kwd><kwd>доклинические исследования</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ethanol</kwd><kwd>acetylcysteine</kwd><kwd>taurine</kwd><kwd>ademetionine</kwd><kwd>preclinical studies</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Данная работа была выполнена при грантовой поддержке Президента Российской Федерации по Соглашению о предоставлении из федерального бюджета грантов в форме субсидий в соответствии с п. 4 ст. 78.1 Бюджетного кодекса Российской Федерации (внутренний номер МК-3454.2019.7) № 075-15-2019-176 от 23.05.2019 г.</funding-statement><funding-statement xml:lang="en">This work was performed with the grant support of the President of the Russian Federation under the Agreement on granting grants from the federal budget in the form of subsidies in accordance with Paragraph 4 of Article 78.1 of the Budget Code of the Russian Federation (the internal number MK-3454.2019.7) No. 075-15-2019-176 dated 23.05.2019.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">van Schrojenstein Lantman M., van de Loo A.J., Mackus M., Verster J.C. Development of a definition for the alcohol hangover: consumer descriptions and expert consensus // Current Drug Abuse Reviews. – 2016. – Vol. 9, No. 2. – P. 148–154. DOI: 10.2174/1874473710666170216125822</mixed-citation><mixed-citation xml:lang="en">van Schrojenstein Lantman M, van de Loo AJ, Mackus M, Verster JC. Development of a definition for the alcohol hangover:consumer descriptions and expert consensus. Current drug abuse reviews. 2016;9(2):148–54. DOI: 10.2174/1874473710666170216125822</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gunn C., Mackus M., Griffin C.A. systematic review of the next-day effects of heavy alcohol consumption on cognitive performance // Addiction (Abingdon, England). – 2018. – Vol. 113, No. 12. – P. 2182–2193. DOI: 10.1111/add.14404</mixed-citation><mixed-citation xml:lang="en">Gunn C, Mackus M, Griffin CA. systematic review of the next-day effects of heavy alcohol consumption on cognitive performance. Addiction (Abingdon, England). 2018;113(12):2182–93. DOI: 10.1111/add.14404</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Palmer E.O.C., Arnoldy L., Ayre E. Proceeding of the 11th alcohol hangover research group meeting in Nadi, Fiji // Proceedings. – 2020. – Vol. 43, No. 1. – P. 1. DOI: 10.3390/proceedings2020043001</mixed-citation><mixed-citation xml:lang="en">Palmer EOC, Arnoldy L, Ayre E. Proceeding of the 11th alcohol hangover research group meeting in Nadi, Fiji. Proceedings. 2020;43(1):1. DOI: 10.3390/proceedings2020043001</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Alford C., Broom C., Carver H. The impact of alcohol hangover on simulated driving performance during a ’commute to work’-zero and residual alcohol effects compared // Journal of Clinical Medicine. – 2020. – Vol. 9, No. 5. – P. 1435. DOI: 10.3390/jcm9051435</mixed-citation><mixed-citation xml:lang="en">Alford C, Broom C, Carver H. The impact of alcohol hangover on simulated driving performance during a ’commute to work’-zero and residual alcohol effects compared. Journal of Clinical Medicine. 2020;9(5):1435. DOI: 10.3390/jcm9051435</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hartung B., Schwender H., Mindiashvili N. The effect of alcohol hangover on the ability to ride a bicycle // International Journal of Legal Medicine. – 2015. – Vol. 129, No. 4. – P. 751–758. DOI: 10.1007/s00414-015-1194-2</mixed-citation><mixed-citation xml:lang="en">Hartung B, Schwender H, Mindiashvili N. The effect of alcohol hangover on the ability to ride a bicycle. International Journal of Legal Medicine. 2015;129(4):751–8. DOI: 10.1007/s00414-015-1194-2</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Devenney L.E., Coyle K.B., Roth T., Verster J.C. Sleep after heavy alcohol consumption and physical activity levels during alcohol hangover // Journal of Clinical Medicine. – 2019. – Vol. 8, No. 5. – P. 752. DOI: 10.3390/jcm8050752</mixed-citation><mixed-citation xml:lang="en">Devenney LE, Coyle KB, Roth T, Verster JC. Sleep after heavy alcohol consumption and physical activity levels during alcohol hangover. Journal of Clinical Medicine. 2019;8(5):752. DOI: 10.3390/jcm8050752</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Penning R., McKinney A., Verster J.C. Alcohol hangover symptoms and their contribution to the overall hangover severity // Alcohol and Alcoholism (Oxford, Oxfordshire). – 2012. – Vol. 47, No. 3. – P. 248–252. DOI: 10.1093/alcalc/ags029</mixed-citation><mixed-citation xml:lang="en">Penning R, McKinney A, Verster JC. Alcohol hangover symptoms and their contribution to the overall hangover severity. Alcohol and Alcoholism (Oxford, Oxfordshire). 2012;47(3):248–52. DOI: 10.1093/alcalc/ags029</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Karadayian A.G., Mac Laughlin M.A., Cutrera R.A. Estrogen blocks the protective action of melatonin in a behavioral model of ethanol-induced hangover in mice // Physiology &amp; Behavior. – 2012. – Vol. 107, No. 2. – P. 181–186. DOI: 10.1016/j.physbeh.2012.07.003</mixed-citation><mixed-citation xml:lang="en">Karadayian AG, Mac Laughlin MA, Cutrera RA. Estrogen blocks the protective action of melatonin in a behavioral model of ethanol-induced hangover in mice. Physiology &amp; Behavior. 2012;107(2):181–6. DOI: 10.1016/j.physbeh.2012.07.003</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Combs D.J., D’Alecy L.G. Motor performance in rats exposed to severe forebrain ischemia: effect of fasting and 1,3-butanediol // Stroke. – 1987. – Vol. 18, No. 2. – P. 503–511. DOI: 10.1161/01.str.18.2.503</mixed-citation><mixed-citation xml:lang="en">Combs DJ, D’Alecy LG. Motor performance in rats exposed to severe forebrain ischemia:effect of fasting and 1,3-butanediol. Stroke. 1987;18(2):503–11. DOI: 10.1161/01.str.18.2.503</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Морковин Е.И., Осадченко Н.А., Кнышова Л.П. Влияние ацетилцистеина на психоневрологические показатели крыс после острой интоксикации этанолом // Вестник Волгоградского Государственного Медицинского Университета. – 2019. – № 3 (71). – С. 110–115. DOI: 10.19163/1994-9480-2019-3(71)-110-1159480</mixed-citation><mixed-citation xml:lang="en">Morkovin EI, Osadchenko NA, Knyshova LP. Effect of acetylcysteine on neuropsychiatric parameters of rats after acute ethanol intoxication. Bulletin of Volgograd State Medical University. 2019;3(71):110–115. DOI: 10.19163/1994-9480-2019-3(71)-110-1159480. Russian</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Морковин Е.И., Куркин Д.В., Тюренков И.Н. Оценка психоневрологического дефицита у грызунов: основные методы // Журнал Высшей Нервной Деятельности им. И. П. Павлова. – 2018. – Т. 68, № 1. – С. 3–15. DOI: 10.7868/S004446771801001X</mixed-citation><mixed-citation xml:lang="en">Morkovin EI, Kurkin DV, Tyurenkov IN. The assessment of the psychoneurological impairments in rodents:basic methods. I.P. Pavlov Journal of Higher Nervous Activity 2018;68(1):3–15. DOI: 10.7868/S004446771801001X. Russian</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kurkin D.V., Morkovin E.I., Osadchenko N.A. N-acetylcysteine relieves neurologic signs of acute ethanol hangover in rats // Research Results in Pharmacology. – 2021. – Vol. 7, No. 1. – P. 75–83. DOI: 10.3897/rrpharmacology.7.62622</mixed-citation><mixed-citation xml:lang="en">Kurkin DV, Morkovin EI, Osadchenko NA. N-acetylcysteine relieves neurologic signs of acute ethanol hangover in rats. Research Results in Pharmacology. 2021;7(1):75–83. DOI: 10.3897/rrpharmacology.7.62622</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kraeuter A.K., Guest P.C., Sarnyai Z. The open field test for measuring locomotor activity and anxiety-like behavior // Methods in Molecular Biology (Clifton, N.J.). – 2019. – No. 1916. – P. 99–103. DOI: 10.1007/978-1-4939-8994-2_9</mixed-citation><mixed-citation xml:lang="en">Kraeuter AK, Guest PC, Sarnyai Z. The open field test for measuring locomotor activity and anxiety-like behavior. Methods Mol Biol. 2019;1916:99–103. DOI: 10.1007/978-1-4939-8994-2_9</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jomova K., Raptova R., Alomar S.Y. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging // Archives of toxicology. – 2023. – Vol. 97, No. 10. – P. 2499–2574. DOI: 10.1007/s00204-023-03562-9</mixed-citation><mixed-citation xml:lang="en">Jomova K, Raptova R, Alomar SY. Reactive oxygen species, toxicity, oxidative stress, and antioxidants:chronic diseases and aging. Archives of Toxicology. 2023;97(10):2499–2574. DOI: 10.1007/s00204-023-03562-9</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kesidou E., Bitsina C., Chatzisotiriou A. N-acetylcysteine administration attenuates sensorimotor impairments following neonatal hypoxic-ischemic brain injury in rats // International Journal of Molecular Sciences. – 2022. – Vol. 23, No. 24. – P. 16175. DOI: 10.3390/ijms232416175</mixed-citation><mixed-citation xml:lang="en">Kesidou E, Bitsina C, Chatzisotiriou A. N-acetylcysteine administration attenuates sensorimotor impairments following neonatal hypoxic-ischemic brain injury in rats. International Journal of Molecular Sciences. 2022;23(24):16175. DOI: 10.3390/ijms232416175</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Coppersmith V., Hudgins S., Stoltzfus J., Stankewicz H. The use of N-acetylcysteine in the prevention of hangover: a randomized trial // Scientific Reports. – 2021. – Vol. 11, No. 1. – P. 13397. DOI: 10.1038/s41598-021-92676-0</mixed-citation><mixed-citation xml:lang="en">Coppersmith V, Hudgins S, Stoltzfus J, Stankewicz H. The use of N-acetylcysteine in the prevention of hangover:a randomized trial. Scientific Reports. 2021;11(1):13397. DOI: 10.1038/s41598-021-92676-0</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ommati M.M., Heidari R., Ghanbarinejad V. Taurine treatment provides neuroprotection in a mouse model of manganism // Biological Trace Element Research. – 2019. – Vol. 190, No. 2. – P. 384–395. DOI: 10.1007/s12011-018-1552-2</mixed-citation><mixed-citation xml:lang="en">Ommati MM, Heidari R, Ghanbarinejad V. Taurine treatment provides neuroprotection in a mouse model of manganism. Biological Trace Element Research. 2019;190(2):384–95. DOI: 10.1007/s12011-018-1552-2</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Prentice H., Gharibani P.M., Ma Z. Neuroprotective functions through inhibition of ER stress by taurine or taurine combination treatments in a rat stroke model // Advances in Experimental Medicine and Biology. – 2017. – No. 975. – P. 193–205. DOI: 10.1007/978-94-024-1079-2_17</mixed-citation><mixed-citation xml:lang="en">Prentice H, Gharibani PM, Ma Z. Neuroprotective functions through inhibition of ER stress by taurine or taurine combination treatments in a rat stroke model. Advances in Experimental Medicine and Biology. 2017;(975):193–205. DOI: 10.1007/978-94-024-1079-2_17</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gupte R., Christian S., Keselman P. Evaluation of taurine neuroprotection in aged rats with traumatic brain injury // Brain Imaging and Behavior. – 2019. – Vol. 13, No. 2. – P. 461–471. DOI: 10.1007/s11682-018-9865-5</mixed-citation><mixed-citation xml:lang="en">Gupte R, Christian S, Keselman P. Evaluation of taurine neuroprotection in aged rats with traumatic brain injury. Brain Imaging and Behavior. 2019;13(2):461–71. DOI: 10.1007/s11682-018-9865-5</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Li F., Jiang H.X., Zhang H.K., Chen Q.X. TUG1 aggravates intracerebral hemorrhage injury by inhibiting angiogenesis in an miR-26a-dependent manner // American Journal of Translational Research. – 2023. – Vol. 15, No. 1. – P. 175–183.</mixed-citation><mixed-citation xml:lang="en">Li F, Jiang HX, Zhang HK, Chen QX. TUG1 aggravates intracerebral hemorrhage injury by inhibiting angiogenesis in an miR-26a-dependent manner. American Journal of Translational Research. 2023;15(1):175–83.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kofler M., Schiefecker A., Ferger B. Cerebral taurine levels are associated with brain edema and delayed cerebral infarction in patients with aneurysmal subarachnoid hemorrhage // Neurocritical Care. – 2015. – Vol. 23, No. 3. – P. 321–329. DOI: 10.1007/s12028-015-0140-y</mixed-citation><mixed-citation xml:lang="en">Kofler M, Schiefecker A, Ferger B. Cerebral taurine levels are associated with brain edema and delayed cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurocritical Care. 2015;23(3):321–9. DOI: 10.1007/s12028-015-0140-y</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mann S.P., Hill M.W. Activation and inactivation of striatal tyrosine hydroxylase: the effects of pH, ATP and cyclic AMP, S-adenosylmethionine and S-adenosylhomocysteine // Biochemical Pharmacology. – 1983. – Vol. 32, No. 22. – P. 3369–3374. DOI: 10.1016/0006-2952(83)90364-7</mixed-citation><mixed-citation xml:lang="en">Mann SP, Hill MW. Activation and inactivation of striatal tyrosine hydroxylase:the effects of pH, ATP and cyclic AMP, S-adenosylmethionine and S-adenosylhomocysteine. Biochemical Pharmacology. 1983;32(22):3369–74. DOI: 10.1016/0006-2952(83)90364-7</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Losada M. E., Rubio M. C. Acute effects of S-adenosyl-L-methionine on catecholaminergic central function // European Journal of Pharmacology. – 1989. – Vol. 163, No. 2–3. – P. 353–356. DOI: 10.1016/0014-2999(89)90205-7</mixed-citation><mixed-citation xml:lang="en">Losada ME, Rubio MC. Acute effects of S-adenosyl-L-methionine on catecholaminergic central function. European Journal of Pharmacology. 1989;163(2-3):353–6. DOI: 10.1016/0014-2999(89)90205-7</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Куркин Д.В., Морковин Е.И., Осадченко Н.А., Кнышова Л.П., Бакулин Д.А., Абросимова Е.Е., Горбунова Ю.В., Тюренков И.Н. Коррекция психоневрологических проявлений алкогольного похмелья у крыс ацетилцистеином // Фармация и фармакология. – 2019. – Т. 7, № 5. – С. 291–299. DOI: 10.19163/2307-9266-2019-7-5-291-299</mixed-citation><mixed-citation xml:lang="en">Kurkin DV, Morkovin EI, Osadchenko NA. Correction of psychological and neurological signs of alcohol hangover in rats with acetylcysteine. Pharmacy &amp; Pharmacology. 2019;7(5):291–9.   DOI: 10.19163/2307-9266-2019-7-5-291-299</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Vohra B.P., Hui X. Improvement of impaired memory in mice by taurine // Neural Plast. – 2000. – Vol. 7. – No. 4. – P. 245–259. DOI: 10.1155/NP.2000.245</mixed-citation><mixed-citation xml:lang="en">Vohra BP, Hui X. Improvement of impaired memory in mice by taurine. Neural Plast. 2000;7(4):245–59. DOI: 10.1155/NP.2000.245</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">SanMiguel N., López-Cruz L., Müller C.E., Salamone J.D., Correa M. Caffeine modulates voluntary alcohol intake in mice depending on the access conditions: Involvement of adenosine receptors and the role of individual differences // Pharmacol Biochem Behav. – 2019. – Vol. 186. – P. 172789. DOI: 10.1016/j.pbb.2019.172789</mixed-citation><mixed-citation xml:lang="en">SanMiguel N, López-Cruz L, Müller CE, Salamone JD, Correa M. Caffeine modulates voluntary alcohol intake in mice depending on the access conditions:Involvement of adenosine receptors and the role of individual differences. Pharmacol Biochem Behav. 2019;186:172789. DOI: 10.1016/j.pbb.2019.172789</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Sehirli O., Tatlidede E., Yüksel M., Erzik C., Cetinel S., Yeğen B.C., Sener G. Antioxidant effect of alpha-lipoic acid against ethanol-induced gastric mucosal erosion in rats // Pharmacology. – 2008. – Vol. 81. – No. 2. – P. 173–180. DOI: 10.1159/000111145</mixed-citation><mixed-citation xml:lang="en">Sehirli O, Tatlidede E, Yüksel M, Erzik C, Cetinel S, Yeğen BC, Sener G. Antioxidant effect of alpha-lipoic acid against ethanol-induced gastric mucosal erosion in rats. Pharmacology. 2008;81(2):173–80. DOI: 10.1159/000111145</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Петров В.И., Григорьев И.А., Горбунов С.Г. Методика исследования зоосоциального поведения крыс в психофармакологии // Экспериментальная и клиническая фармакология. – 1996. – Т. 59, № 4. – С. 65–69.</mixed-citation><mixed-citation xml:lang="en">Petrov VI, Grigoriev IA, Gorbunov SG. Methodology for the study of zoosocial behavior of rats in psychopharmacology. Experimental and Clinical Pharmacology. 1996;59(4):65–9. Russian</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobs G.H., Fenwick J.A., Williams G.A. Cone-based vision of rats for ultraviolet and visible lights // The Journal of Experimental Biology. – 2001. – Vol. 204, No. 14. – P. 2439–2446. DOI: 10.1242/jeb.204.14.2439</mixed-citation><mixed-citation xml:lang="en">Jacobs GH, Fenwick JA, Williams GA. Cone-based vision of rats for ultraviolet and visible lights. The Journal of Experimental Biology. 2001;204(14):2439–46. DOI: 10.1242/jeb.204.14.2439</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Agnes J.P., Dos Santos V.W., das Neves R.N. Antioxidants improve oxaliplatin-induced peripheral neuropathy in tumor-bearing mice model: role of spinal cord oxidative stress and inflammation // The Journal of Pain. – 2021. – No. 8. – P. 996–1013. DOI: 10.1016/j.jpain.2021.03.142</mixed-citation><mixed-citation xml:lang="en">Agnes JP, Dos Santos VW, das Neves RN. Antioxidants improve oxaliplatin-induced peripheral neuropathy in tumor-bearing mice model:role of spinal cord oxidative stress and inflammation. The Journal of Pain. 2021;(8):996–1013. DOI: 10.1016/j.jpain.2021.03.142</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Elsayed A., Elkomy A., Elkammar R. Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats // Scientific Reports. – 2021. – Vol. 11, No. 1. – P. 13979. DOI: 10.1038/s41598-021-93196-7</mixed-citation><mixed-citation xml:lang="en">Elsayed A, Elkomy A, Elkammar R. Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats. Scientific Reports. 2021;11(1):13979. DOI: 10.1038/s41598-021-93196-7</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Liao C. Y., Wu T. C., Yang S. F., Chang J. T. Effects of NAC and gallic acid on the proliferation inhibition and induced death of lung cancer cells with different antioxidant capacities // Molecules (Basel, Switzerland). – 2021. – Vol. 27, No. 1. – P. 75. DOI: 10.3390/molecules27010075</mixed-citation><mixed-citation xml:lang="en">Liao CY, Wu TC, Yang SF, Chang JT. Effects of NAC and gallic acid on the proliferation inhibition and induced death of lung cancer cells with different antioxidant capacities. Molecules (Basel, Switzerland). 2021;27(1):75. DOI: 10.3390/molecules27010075</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Anastasi E., Scaramuzzino S., Viscardi M.F. Efficacy of n-acetylcysteine on endometriosis-related pain, size reduction of ovarian endometriomas, and fertility outcomes // International Journal of Environmental Research and Public Health. – 2023. – Vol. 20, No. 6. – P. 4686. DOI: 10.3390/ijerph20064686</mixed-citation><mixed-citation xml:lang="en">Anastasi E, Scaramuzzino S, Viscardi MF. Efficacy of n-acetylcysteine on endometriosis-related pain, size reduction of ovarian endometriomas, and fertility outcomes. International Journal of Environmental Research and Public Health. 2023;20(6):4686. DOI: 10.3390/ijerph20064686</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Siemsen B.M., Denton A.R., Parrila-Carrero J. Heroin self-administration and extinction increase prelimbic cortical astrocyte-synapse proximity and alter dendritic spine morphometrics that are reversed by N-acetylcysteine // Cells. – 2023. – Vol. 12, No. 14. – P. 1812. DOI: 10.3390/cells12141812</mixed-citation><mixed-citation xml:lang="en">Siemsen BM, Denton AR, Parrila-Carrero J. Heroin self-administration and extinction increase prelimbic cortical astrocyte-synapse proximity and alter dendritic spine morphometrics that are reversed by N-acetylcysteine. Cells. 2023;12(14):1812. DOI: 10.3390/cells12141812</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Sun J., Guo F., Ran J. Bibliometric and visual analysis of global research on taurine, creatine, carnosine, and anserine with metabolic syndrome: from 1992 to 2022 // Nutrients. – 2023. – Vol. 15, No. 15. – P. 3374. DOI: 10.3390/nu15153374</mixed-citation><mixed-citation xml:lang="en">Sun J, Guo F, Ran J. Bibliometric and visual analysis of global research on taurine, creatine, carnosine, and anserine with metabolic syndrome:from 1992 to 2022. Nutrients. 2023;15(15):3374. DOI: 10.3390/nu15153374</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Анциферов М.Б. Роль таурина и его дефицита в организме человека и животных // Фарматека. – 2012. – Т. 16, № 249. – С. 60–78.</mixed-citation><mixed-citation xml:lang="en">Antsiferov MB. Role of taurine and its deficiency in the human and animal organism. Pharmateka. 2012;16(249):60–78. Russian</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Saccarello A., Montarsolo P., Massardo I. Oral administration of S-adenosylmethionine (SAMe) and lactobacillus plantarum HEAL9 improves the mild-to-moderate symptoms of depression: a randomized, double-blind, placebo-controlled study // The Primary Care Companion for CNS Disorders. – 2020. – Vol. 22, No. 3. – P. 19m02578. DOI: 10.4088/PCC.19m02578</mixed-citation><mixed-citation xml:lang="en">Saccarello A, Montarsolo P, Massardo I. Oral administration of S-adenosylmethionine (SAMe) and lactobacillus plantarum HEAL9 improves the mild-to-moderate symptoms of depression:a randomized, double-blind, placebo-controlled study. The Primary Care Companion for CNS Disorders. 2020;22(3):19m02578. DOI: 10.4088/PCC.19m02578</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Tillmann S., Happ D.F., Mikkelsen P.F. Behavioral and metabolic effects of S-adenosylmethionine and imipramine in the Flinders Sensitive Line rat model of depression // Behavioural Brain Research. – 2019. – No. 364. – P. 274–280. DOI: 10.1016/j.bbr.2019.02.011</mixed-citation><mixed-citation xml:lang="en">Tillmann S, Happ DF, Mikkelsen PF. Behavioral and metabolic effects of S-adenosylmethionine and imipramine in the Flinders Sensitive Line rat model of depression. Behavioural Brain Research. 2019;(364):274–80. DOI: 10.1016/j.bbr.2019.02.011</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Ullah H., Di Minno A., Esposito C. Efficacy of a food supplement based on S-adenosyl methionine and probiotic strains in subjects with subthreshold depression and mild-to-moderate depression: A monocentric, randomized, cross-over, double-blind, placebo-controlled clinical trial // Biomedicine &amp; Pharmacotherapy. – 2022. – No. 156. – P. 113930. DOI: 10.1016/j.biopha.2022.113930</mixed-citation><mixed-citation xml:lang="en">Ullah H, Di Minno A, Esposito C. Efficacy of a food supplement based on S-adenosyl methionine and probiotic strains in subjects with subthreshold depression and mild-to-moderate depression:A monocentric, randomized, cross-over, double-blind, placebo-controlled clinical trial. Biomedicine &amp; Pharmacotherapy. 2022;(156):113930. DOI: 10.1016/j.biopha.2022.113930</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Noureddin M., Sander-Struckmeier S., Mato J.M. Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review // World journal of hepatology. – 2020. – Vol. 12, No. 2. – P. 46–63. DOI: 10.4254/wjh.v12.i2.46</mixed-citation><mixed-citation xml:lang="en">Noureddin M, Sander-Struckmeier S, Mato JM. Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis:A systematic review. World journal of hepatology. 2020;12(2):46–63. DOI: 10.4254/wjh.v12.i2.46</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Морковин Е.И., Осадченко Н.А., Куркин Д.В. Коррекция токсических эффектов этанола у крыс при помощи перорального введения ацетилцистеина // Волгоградский Научно-Медицинский Журнал. – 2019. – № 4. – С. 43–46.</mixed-citation><mixed-citation xml:lang="en">Morkovin EI, Osadchenko NA, Kurkin DV. Correction of toxic effects of ethanol in rats by oral administration of acetylcysteine. Volgograd Scientific Medical Journal. 2019;(4):43–46. Russian</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Otero-Losada M.E., Rubio M.C. Acute changes in 5-HT metabolism after S-adenosyl-L-methionine administration // General Pharmacology. – 1989. – Vol. 20, No. 4. – P. 403–406. DOI: 10.1016/0306-3623(89)90186-9</mixed-citation><mixed-citation xml:lang="en">Otero-Losada ME, Rubio MC. Acute changes in 5-HT metabolism after S-adenosyl-L-methionine administration. General Pharmacology. 1989;20(4):403–6. DOI: 10.1016/0306-3623(89)90186-9</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Kirson D., Oleata C.S., Roberto M. Taurine suppression of central amygdala GABAergic inhibitory signaling via glycine receptors Is disrupted in alcohol dependence // Alcoholism, Clinical and Experimental Research. – 2020. – Vol. 44, No. 2. – P. 445–454. DOI: 10.1111/acer.14252</mixed-citation><mixed-citation xml:lang="en">Kirson D, Oleata CS, Roberto M. Taurine suppression of central amygdala GABAergic inhibitory signaling via glycine receptors Is disrupted in alcohol dependence. Alcoholism, Clinical and Experimental Research. 2020;44(2):445–54. DOI: 10.1111/acer.14252</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
